Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma
Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.
Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page
- CheckyesterdayChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has added new features for data download options, including formats like CSV, JSON, and FHIR, while removing several key government health-related links.SummaryDifference14%
- Check22 days agoChange DetectedNew resources have been added, including links to HHS, NIH, NLM, NCBI, and USA.gov, enhancing the website's informational offerings.SummaryDifference0.7%
- Check30 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in various file formats and enhanced data field selection for studies.SummaryDifference16%
- Check37 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.7%
Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma
Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.